Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of an antitumor agent versus bevacizumab in Japan
jRCT2080222965Phase 3Completed
- Start
- Sep 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3 trial of bevacizumab in cancer (2 arms). Started Sep 2015; status: completed.
02
Drugs
bevacizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222965.